Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

41.10

-2.64 (-6.04%)

At close: Feb 27, 2026, 4:00 PM EST

41.05

-0.05 (-0.12%)

After-hours: Feb 27, 2026, 7:04 PM EST

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,303	4,417	4,742	2,377	985	1,340
Market Cap Growth	31.79%	-6.84%	99.50%	141.36%	-26.50%	188.40%
Enterprise Value	3,324	3,374	3,932	1,874	620	1,151
Last Close Price	41.10	46.55	51.13	35.58	18.30	28.41
PS Ratio	559.17	573.96	4563.69	592.26	207.88	1242.80
PB Ratio	3.96	4.45	3.58	4.41	3.11	4.04
P/TBV Ratio	4.34	4.45	3.58	4.41	3.11	4.04
EV/Sales Ratio	431.92	438.42	3783.97	467.04	130.82	1067.39
Debt / Equity Ratio	0.05	0.05	0.04	0.10	0.01	0.01
Net Debt / Equity Ratio	-0.99	-0.99	-0.98	-0.94	-1.05	-0.99
Net Debt / EBITDA Ratio	1.91	1.91	3.88	2.29	1.99	3.09
Net Debt / FCF Ratio	2.55	2.55	5.67	2.96	2.84	3.70
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.00
Quick Ratio	12.09	12.09	22.83	12.92	12.17	20.96
Current Ratio	12.32	12.32	23.05	13.07	12.45	21.55
Return on Equity (ROE)	-40.17%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-25.22%	-25.22%	-20.46%	-28.18%	-29.84%	-25.19%
Return on Capital Employed (ROCE)	-49.60%	-49.60%	-24.60%	-37.60%	-51.70%	-32.10%
Earnings Yield	-10.81%	-10.53%	-6.29%	-9.03%	-16.65%	-8.04%
FCF Yield	-8.92%	-8.69%	-4.85%	-7.20%	-11.87%	-6.64%
Buyback Yield / Dilution	-16.43%	-16.43%	-39.11%	-11.71%	-35.24%	-26.24%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q